美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

美國抗疫概念

1,725.84

+3.120.18%

漲家數：5

跌家數：14

平家數：- -

市盈率：- -

高：1,728.92

開：1,720.49

低：1,704.72

收：1,722.72

成交量：9,734.43萬

成交額：59.84億

市值：1.41萬億

流通市值：1.39萬億

資料載入中...

總覽新聞資訊

輝瑞報告萊姆病疫苗有效性達73%，試驗結果使前景複雜化

环球市场播报

Aethlon Medical, Inc. 獲獨立數據監察委員會積極評估後，進入腫瘤臨床試驗最終隊列

Aethlon Medical Inc：數據安全監查委員會同時指出「Hemopurifier設備/操作未發現安全問題」

BUZZ-基因療法在晚期眼病試驗中延緩視力衰退，Ocugen 公司股價上漲

Ocugen公布Ocu410修飾基因療法治療乾性年齡相關性黃斑變性繼發地圖樣萎縮的二期Armada臨床試驗12個月頂線數據

今日優惠-合併與收購

輝瑞萊姆病疫苗有效率73%，惟試驗結果存不確定性

新聞摘要-華爾街日報》--3 月 24 日

吉利德科學保留大中華區以外全球獨家商業化權利，將向Galapagos支付銷售額20%-23%的特許權使用費

吉利德科學將以16.75億美元現金對價收購Ouro Medicines全部流通股權

吉利德科學正與Galapagos就收購的Ouro Medicines資產展開研發合作深入談判

吉利德科學將收購Ouro Medicines，推進其首創的T細胞銜接器項目以治療自身免疫性疾病

據英國《金融時報》報導，吉利德接近以最高20億美元收購生物技術公司Ouro Medicines

吉利德科學與Ouro Medicines談判進入後期階段交易有望近日公布

吉利德科學將以約15億美元現金預付款收購Ouro，若臨床試驗達標還將額外支付至少5億美元

BUZZ-Valneva股價暴跌，因萊姆病疫苗後期試驗未達標

輝瑞與Valneva聯合宣佈：萊姆病候選疫苗在3期VALOR試驗中展現強勁效力

輝瑞萊姆病候選疫苗Lb6v在五歲及以上人群中預防效力超70%

輝瑞：Lb6v候選疫苗耐受性良好分析時未發現安全性問題

輝瑞-Valneva 萊姆病疫苗在後期試驗中顯示出超過 70% 的療效

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1725.8383,"timestamp":1774382399999,"preClose":1722.715,"halted":0,"volume":97344285,"delay":0,"changeRate":0.001813,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":3.123291,"latestTime":"03-24 16:00:00 EDT","open":1720.4874,"high":1728.9202,"low":1704.7186,"amount":5983504235.268287,"amplitude":0.014048,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.348775,"peRate":25.395225,"turnoverRate":0.007026,"increases":5,"decrements":14,"flats":0,"marketCap":1407660307258.25,"floatMarketCap":1388438999490.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1728.9202,"amplitude":0.014048,"preClose":1722.715,"low":1704.7186,"pbRate":"4.348775","latestPrice":1725.8383,"volume":97344285,"delay":0,"open":1720.4874,"prevYearClose":1637.1339,"prevWeekClose":1724.4738,"prevMonthClose":1860.0614,"prevQuarterClose":1637.1339,"fiveDayClose":1775.5172,"twentyDayClose":1839.7878,"sixtyDayClose":1647.5189,"secType":"PLATE","market":"US","turnoverRate":0.007026,"peRate":25.395225,"marketCap":1407660307258.25,"floatMarketCap":1388438999490.25,"timestamp":1774382399999,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":14,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621095724","title":"輝瑞報告萊姆病疫苗有效性達73%，試驗結果使前景複雜化","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095724","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621095724?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 22:58","pubTimestamp":1774364280,"startTime":"0","endTime":"0","summary":"随着其莱姆病疫苗试验的早期数据开始显现，辉瑞正接近其后疫情时代转型中一个潜在的重要转折点，尽管这一结果可能仍会留有争议空间。该公司报告称，与瓦尔内瓦公司合作开发的实验性疫苗针对这种蜱传疾病显示出73%的有效性，但研究中观察到的感染病例数量低于预期，使得总体有效性的全面解读变得更为困难。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-24/doc-inhschns4072029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LU1023059063.AUD","LU0306807586.USD","SG9999003800.SGD","BK4592","LU1066051498.USD","LU0456855351.SGD","BK4550","LU1894683348.USD","LU0985481810.HKD","LU0170899867.USD","SG9999001176.USD","LU0868494617.USD","SG9999013999.USD","IE0002270589.USD","BK4585","SG9999001176.SGD","BK4568","BK4588","BK4581","LU0122379950.USD","LU0321505868.SGD","BK4599","LU0058720904.USD","LU1066053197.SGD","LU1894683264.USD","BK4007","SG9999011175.SGD","SG9999002224.SGD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU1883839398.USD","LU0225284248.USD","LU1057294990.SGD","LU0289739699.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","SG9999002232.USD","LU0225771236.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0234572021.USD","BK4533","IE000M9KFDE8.USD","PFE"],"gpt_icon":0},{"id":"1157103229","title":"Aethlon Medical, Inc. 獲獨立數據監察委員會積極評估後，進入腫瘤臨床試驗最終隊列","url":"https://stock-news.laohu8.com/highlight/detail?id=1157103229","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157103229?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 20:09","pubTimestamp":1774354171,"startTime":"0","endTime":"0","summary":"在独立数据监察委员会（DSMB）进行积极审查后，Aethlon Medical, Inc. 已获准推进其肿瘤学临床试验的最终队列阶段。这一进展标志着该公司在开发新型癌症治疗方法方面迈出了关键一步。最终队列的启动将为评估该疗法的安全性和有效性提供更为全面的数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4082","BK4583","BK4568"],"gpt_icon":0},{"id":"1156861388","title":"Aethlon Medical Inc：數據安全監查委員會同時指出「Hemopurifier設備/操作未發現安全問題」","url":"https://stock-news.laohu8.com/highlight/detail?id=1156861388","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156861388?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 20:06","pubTimestamp":1774353978,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc宣布，其数据安全监查委员会（DSMB）在审查后确认，Hemopurifier设备及相关操作流程未发现任何安全隐患。这一声明进一步支持了该医疗设备在临床试验中的安全性表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","BK4583","AEMD"],"gpt_icon":0},{"id":"2621061776","title":"BUZZ-基因療法在晚期眼病試驗中延緩視力衰退，Ocugen 公司股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2621061776","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621061776?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 19:59","pubTimestamp":1774353553,"startTime":"0","endTime":"0","summary":"BUZZ-基因疗法在晚期眼病试验中延缓视力衰退，Ocugen 公司股价上涨3月24日 - ** 生物技术公司OcugenOCGN.O的股价盘前上涨4.2%至2.19美元** 该公司称其实验性基因疗法减缓了地理萎缩的疾病进展，地理萎缩是一种晚期眼病，会导致老年人视力下降** 公司称，中期试验表明，OCU410能在12个月内将损害视力的眼部病变的生长速度降低31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL4S40C0ZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","OCGN","BK4139","BK4568"],"gpt_icon":0},{"id":"1114286801","title":"Ocugen公布Ocu410修飾基因療法治療乾性年齡相關性黃斑變性繼發地圖樣萎縮的二期Armada臨床試驗12個月頂線數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1114286801","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114286801?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 19:46","pubTimestamp":1774352776,"startTime":"0","endTime":"0","summary":"Ocugen公司今日宣布，其针对干性年龄相关性黄斑变性继发地图样萎缩的Ocu410修饰基因疗法，在二期Armada临床试验中取得了为期12个月的顶线数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","OCGN","BK4563","BK4139"],"gpt_icon":0},{"id":"2621483068","title":"今日優惠-合併與收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2621483068","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621483068?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 17:35","pubTimestamp":1774344949,"startTime":"0","endTime":"0","summary":"今日优惠-合并与收购路透3月24日 - 截至GMT周二上午 9 时 30 分，报道了以下竞标、兼并、收购和处置活动：** 国家支持的意大利邮政< PST.MI  >提出了一项108亿欧元 现金加股票的收购要约，以将意大利电信 < TLIT.MI  > 收归国有，这是在一次不成功的私有化约三十年后。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL4S40C0PZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BK4230","IE00BZ1G4Q59.USD","BK4583","LU2112291526.USD","LU2324357040.USD","SG9999002620.SGD","LU0320765992.SGD","IE00B19Z3581.USD","LU0532188223.SGD","SGXZ23171101.USD","IE00B3T34201.USD","LU0122379950.USD","BK5152","BK4529","LU1196525536.USD","LU0788108743.HKD","SG9999002679.SGD","LU1066053197.SGD","SG9999013460.SGD","SG9999002414.USD","LU2362541273.HKD","LU1046248800.SGD","LU1934455194.USD","LU1023059063.AUD","LU1242518857.USD","SGXZ58947870.SGD","LU0526926950.USD","IE00B19Z3B42.SGD","LU1668664300.SGD","SG9999015986.USD","LU2087621335.USD","LU0648000940.SGD","GILD","BK4175","LU0971552673.USD","LU0210637038.USD","LU0058720904.USD","LU1061106388.HKD","LU2045819591.USD","COR","LU0234570918.USD","LU1261432733.SGD","BK4532","BK4122","LU1839390173.USD","LU1037948897.HKD","LU0575583348.USD","SG9999002406.SGD","BK4019","LU1839511570.USD","LU0211331839.USD","LU0889565916.HKD","LU0128525689.USD","LU1880407132.USD","LU1934455863.HKD","SG9999015945.SGD","BK4559","IE00B7SZLL34.SGD","IE0002270589.USD","LU0861579265.USD","LU2468319806.SGD","LU1674673691.USD","SG9999013486.USD","LU0106831901.USD","LU0130518102.USD","LU0289739699.SGD","BK4578","LU1880407215.USD","SG9999006266.SGD","LU0171293334.USD","LU0211328371.USD","BK4568","LU1023061473.USD","SG9999015978.USD","LU0211327993.USD","LU0109394709.USD","LU1023061713.HKD",".IXIC","LU1571399168.USD","LU2125910500.SGD","IE00BSNM7G36.USD","SG9999013478.USD","SG9999015952.SGD","LU0965509101.SGD","LU1267930227.SGD","LU0823416689.USD","TM","LU0965509283.SGD","BK4550","LU2237957902.USD","LU1267930490.SGD","LU1057294990.SGD","LU0130103400.USD","IE00BKVL7J92.USD","LU1934455277.USD","LU0052756011.USD","LU0963555726.SGD","LU1674673428.USD","LU1242518931.SGD","LU0965508806.USD","LU0769137737.USD","LU1585245621.USD","BK4588","LU1037948541.HKD","SG9999004303.SGD","LU1119994496.HKD","BK4127","BRK.A","LU1430594728.SGD","SG9999002604.SGD","LU0310799852.SGD","BK4566","BK4084","LU0477156797.USD","LU0171280430.USD","LU0965509010.AUD","EG","BK4022","JEF","LU1015430645.USD","LU1201861165.SGD","LU1302929846.USD","LU1778281490.HKD","LU0171281750.USD","LU1066051498.USD","LU1814569148.SGD","LU2362540622.SGD","LU0971552830.HKD","LU1084165304.USD","LU2237957811.SGD","LU0114720955.EUR","LU0077335932.USD","GRAB","LU0979878070.USD","SG9999001135.SGD","LU0882574055.USD","BK4585","LU2362541513.USD","LU0441851309.USD","BK4139","LU0310800965.SGD"],"gpt_icon":0},{"id":"2621055728","title":"輝瑞萊姆病疫苗有效率73%，惟試驗結果存不確定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055728","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621055728?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 14:33","pubTimestamp":1774334009,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4550","LU0122379950.USD","LU0306807586.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","LU1066051498.USD","PFE","LU1066053197.SGD","SG9999011175.SGD","SG9999013999.USD","IE00BLSP4239.USD","LU1023059063.AUD","BK4568","LU0321505439.SGD","IE00B19Z3581.USD","BK4592","IE0002270589.USD","IE00BLSP4452.SGD","SG9999002224.SGD","SGXZ57979304.SGD","BK4007","SG9999003800.SGD","LU0868494617.USD","LU0170899867.USD","IE00BBT3K403.USD","BK4585","LU1057294990.SGD","LU1894683264.USD","LU0289739699.SGD","LU1883839398.USD","LU0225284248.USD","LU0456855351.SGD","SG9999001176.SGD","LU0321505868.SGD","LU1894683348.USD","SG9999002232.USD","BK4581","BK4533","SG9999001176.USD","IE000M9KFDE8.USD","LU0058720904.USD","LU0225771236.USD","BK4588","BK4599","BK4534","LU0306806265.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2621905564","title":"新聞摘要-華爾街日報》--3 月 24 日","url":"https://stock-news.laohu8.com/highlight/detail?id=2621905564","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621905564?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 14:18","pubTimestamp":1774333134,"startTime":"0","endTime":"0","summary":"新闻摘要-华尔街日报》--3 月 24 日路透3月24日 - 以下是《华尔街日报》的热门新闻。路透未对这些报道进行核实，也不保证其准确性。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL4S40C0EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","LU2111349929.HKD","BK4555","LU1116320901.HKD","LU2360032135.SGD","LU2505996509.AUD","LU0320765059.SGD","LU0267386448.USD","LU0353189680.USD","BK4612","BK4538","LU2361045086.USD","LU1202635105.USD","LU0871640123.AUD","LU0879622024.SGD","LU0109392836.USD","LU0345768153.USD","LU0943347566.SGD","LU2491050071.SGD","LU0784384876.USD","SG9999014898.SGD","TSYY","BK0183","LU2237957811.SGD","LU2362541273.HKD","SG9999001424.SGD","IE00BWXC8680.SGD","LU2473716301.USD","LU0390134368.USD","LU0124676726.USD","IE00BMPRXN33.USD","SG9999015341.SGD","LU1935042215.USD","IE0001KFT4U8.USD","LU0861579265.USD","LU0889566641.SGD","LU1334329650.SGD","LU1720051017.SGD","LU0979878070.USD","LU2237443382.USD","LU1003077747.HKD","BK4534","TSLW","LU0256863811.USD","IE0004086264.USD","BK4097","LU1997245094.SGD","LU0114720955.EUR","LU1235294995.USD","LU1564329461.SGD","BK4598","TEST","BK4139","IE00BFXG0V08.USD","BK4551","LU0289739699.SGD","LU1146622755.USD","LU1989764748.USD","LU0640476718.USD","LU2543165471.USD","LU0314104364.USD","BK4507","LU1571399168.USD","LU0072461881.USD","LU0823417653.USD","IE000KEQY171.SGD","LU1066051498.USD","SG9999000418.SGD","LU2495084118.USD","LU1057294990.SGD","LU0068578508.USD","IE00BJTD4N35.SGD","IE00BQXX3F31.USD","LU1489326972.SGD","LU1969619763.USD","IE00B5949003.HKD","LU0210528500.USD","LU0980610538.SGD","LU2148611432.USD","LU2290526834.HKD","SG9999014575.USD","LU1221951129.SGD","LU1861214812.USD","SG9999002232.USD","LU2456880835.USD","LU2237443895.HKD","LU1934455194.USD","LU2237443978.SGD","IE00BQXX3D17.EUR","LU1196500208.SGD","LU0823421416.USD","LU1061106388.HKD","LU1803068979.SGD","LU2361044949.HKD","BK4504","LU0689626769.HKD","SGXZ31699556.SGD","LU0889565833.HKD","IE00BSNM7G36.USD","LU0069063385.USD","LU1674673691.USD","LU2210150020.SGD","LU0823434740.USD","LU1066051811.HKD","LU0170899867.USD","LU1645745479.HKD","LU1983260115.SGD","LU0109394709.USD","LU1582986359.USD","LU0878866978.SGD","LU2125909247.SGD","LU1670710661.SGD","LU2430703251.USD","LU2462157665.USD","LU2065171402.SGD","SG9999001077.SGD","IE0009356076.USD","LU2413666699.HKD","LU1815336760.USD","LU0211327993.USD","IE0034235188.USD","LU0225283273.USD","MSFU","IE00BHPRN162.USD","LU0965509010.AUD","LU0345774391.USD","LU1691799644.USD","IE00BDCRKT87.USD","BK4533","SG9999014906.USD","LU1868837136.USD","BK0072","BK4527","LU1127390331.HKD","LU2430703095.HKD","LU1116320737.USD","LU2487616109.SGD","LU1712237335.SGD","LU2237957902.USD","LU1917777945.USD","LU1119994496.HKD","LU0345770308.USD","LU2491050154.USD","LU2023251221.USD","LU1564329032.USD","LU0726765562.USD","LU2041044095.USD","LU0342679015.USD","LU1069347547.HKD","SG9999018857.SGD","BK4578","LU0048584097.USD","LU0792757196.USD","LU1974910355.USD","SG9999018865.SGD","LU0690374615.EUR","BK4604","GILD","LU2317271919.USD","LU0672654240.SGD","LU0795875086.SGD","LU2580892789.USD","LU1074936037.SGD","LU1235295455.SGD","LU2097344357.USD","LU0149725797.USD","LU0426417589.USD","IE00BKVL7J92.USD","LU1435385759.SGD","SG9999015952.SGD","LU0203201768.USD","LU1732799900.SGD","LU2506951875.HKD","LU0719512351.SGD","LU0964807845.USD","LU0426412945.USD","LU2720916845.USD","LU2860962120.EUR","BK4574","LU1997244956.HKD","IE0005OL40V9.USD","LU2552382215.SGD","IE00BJLML261.HKD","LU0128525929.USD","LU0320765489.SGD","LU0882574055.USD","LU1153585028.USD","LU2663582299.SGD","LU1429558221.USD","LU0661504455.SGD","LU1064131342.USD","LU1066051225.USD","IE0009G5SDU7.USD","LU0784385170.HKD","LU2089284900.SGD","LU0203202063.USD","LU0061474705.USD","LU1732800096.USD","GB00B4QBRK32.GBP","BK4543","IE00B5TLWC47.USD","IE00BJTD4V19.USD","LU1228905037.USD","LU0708995401.HKD","LU1934455863.HKD","LU2242649171.HKD","LU0823416689.USD","LU0882574139.USD","LU0011850046.USD","LU2326559502.SGD","LU0203347892.USD","BK4525","07766","LU1914381329.SGD","LU2063271972.USD","IE00BYXW3230.USD","LU0316494557.USD","LU0203345920.USD","LU1201861249.SGD","IE00BN29S564.USD","LU2362541513.USD","LU2265009873.SGD","IE00B3SWFQ91.USD","LU1564329115.USD","LU2360108059.USD","SGXZ99366536.SGD","LU2087625088.SGD","LU1242518931.SGD","LU0784383803.USD","LU0985320562.USD","LU1400636657.SGD","IE00B19Z3581.USD","LU0690374961.EUR","LU2097344431.USD","SG9999014567.USD","MSFY","IE0003U64NQ7.SGD","LU0787776722.HKD","LU0323239441.USD","LU0082616367.USD","LU0472753341.HKD","LU1861215975.USD","LU1035773651.USD","LU2347655073.USD","TSLY","LU0433182093.SGD","BK4532","LU1935042991.SGD","LU0511384066.AUD","LU0061474960.USD","LU0345769128.USD","LU1935043536.SGD","LU0553294199.USD","LU0985489474.SGD","LU1861219969.SGD","LU1023059063.AUD","LU1820825898.SGD","LU2420271590.USD","IE00B19Z9505.USD","LU0354030438.USD","LU2361044865.SGD","LU0545039389.USD","LU1496350171.SGD","TSLQ","LU2272731782.SGD","LU0708994859.HKD","LU0210536198.USD","LU0266013472.USD","LU1839511570.USD","LU2168564065.EUR","IE00BYQQ9H92.USD","LU1242518857.USD","LU2360106780.USD","LU0122379950.USD","LU1261432733.SGD","LU0234572021.USD","LU2065170008.USD","LU1861127337.USD","LU0757359368.USD","LU0157215616.USD","SG9999015986.USD","EVS.SI","LU0528227936.USD","BK4524","LU1670756490.USD","LU1868836914.USD","LU1861220033.SGD","LU2298321311.HKD","SG9999015978.USD","LU2506952170.USD","LU2552382058.USD","LU1642822529.SGD","LU2322448791.USD","LU1697837992.HKD","TESL","LU0079474960.USD","BK0155","LU2764263203.CNY","IE00B7SZLL34.SGD","LU2461242641.AUD","BK4576","BK4581","LU1989772840.SGD","LU2506952097.USD","BK0264","LU1992135399.USD","LU1267930730.SGD","LU0345768740.USD","LU0347712357.USD","IE00BKDWB100.SGD","LU0642271901.SGD","LU2112291526.USD","LU0323591593.USD","LU0738911758.USD","LU2328871848.SGD","LU2458330243.SGD","LU2750360641.GBP","TSLG","LU0175139822.USD","LU2279689827.SGD","LU0072462426.USD","LU2023250504.SGD","IE00BLSP4452.SGD","LU1121112475.USD","BK4535","LU2322448957.HKD","LU1043141123.HKD","LU1032466523.USD","BK4554","BK4550","IE0004445239.USD","LU0894486033.HKD","LU0215105999.USD","LU0957791311.USD","LU0444971666.USD","LU1564329628.SGD","LU2357305700.SGD","LU2471134952.CNY","IE00BQXX3C00.GBP","LU1043141396.HKD","LU1992135472.HKD","LU0795875169.SGD","LU1035775433.USD","LU0960925559.SGD","LU0545562505.USD","LU1852331112.SGD","LU2087621335.USD","LU1781817850.SGD","TSII","LU0494093205.USD","SG9999014559.SGD","LU2237438978.USD","LU0312595415.SGD","LU1400636491.USD","LU0276348264.USD","LU0965509101.SGD","IE00BFSS8Q28.SGD","LU1232071149.USD","LU2237443622.USD","LU1951198990.SGD","TSLI","LU1064131003.USD","LU0823414478.USD","LU1670627923.USD","LU0757359954.USD","TLA","TSLR","LU2168564495.EUR","LU2404859667.USD","IE00B3S45H60.SGD","LU0823421333.USD","LU1814569148.SGD","LU2065171311.SGD","LU0127658192.USD","LU1670711123.USD","SG9999015358.SGD","LU0154236417.USD","LU0265550359.USD","LU1585245621.USD","LU1791710400.SGD","LU2362540622.SGD","LU1066053197.SGD","BRK.A","IE00BLSP4239.USD","BK4585","LU0949170772.SGD","BK4077","LU0965509283.SGD","LU0786609619.USD","TSDD","LU1989763005.USD","IE00B775SV38.USD","LU1551013425.SGD","LU2054465674.USD","LU1720051108.HKD","LU0251132253.USD","LU1803068623.USD","LU1923623000.USD","TSLZ","MSFX","LU2065169927.USD","LU2089283258.USD","IE00B19Z8X17.USD","IE00BKPKM429.USD","LU2125154935.USD","LU1430594728.SGD","HK0000914686.HKD","LU0211328371.USD","LU0950375773.USD","BK4577","LU0894485498.HKD","LU2471134796.USD","LU0476273544.USD","LU2092937221.SGD","LU1670710588.SGD","IE00BZ1G4Q59.USD","TSLP","LU0302445910.USD","LU2092937148.SGD","LU2491049909.HKD","IE00B7KXQ091.USD","LU1934455277.USD","LU0162691827.USD","LU1951200564.SGD","BK0196","LU1064130708.USD","LU0823417737.USD","LU1861559042.SGD","LU2244417387.USD","IE0034235303.USD","LU0053666078.USD","LU0210533765.USD","LU2272731865.HKD","IE00B1XK9C88.USD","LU0265550946.USD","LU2413666426.HKD","LU1069344957.HKD","LU0289739343.SGD","LU0234570918.USD","BK4583","LU1244550494.USD","IE00B4YYXB79.USD","LU2023250843.SGD","LU2168564149.EUR","LU2756315318.SGD","LU2286300806.USD","LU0345774631.USD","SG9999014542.SGD","LU1340139317.AUD","LU1032955483.USD","LU1868836591.USD","LU1989772923.USD","LU1989773731.SGD","BK4568","LU1508157978.USD","BK4579","LU2764263039.SGD","LU1366192091.USD","LU1823568750.SGD","LU0912757837.SGD","LU2468319806.SGD","LU2083900584.USD","LU1145028129.USD","LU0107464264.USD","CRSH","LU0077335932.USD","LU2249611893.SGD","LU1267930813.SGD","BK4503","LU0096364046.USD","LU2237443465.HKD","LU1935043023.USD","LU2247934214.USD","LU0444973449.USD","SG9999014914.USD","LU2471134879.HKD","SG9999017495.SGD","LU0648001328.SGD","LU0354030511.USD","IE00BBT3K403.USD","LU0057025933.USD","LU1221951046.USD","SG9999004303.SGD","LU0683600562.USD","LU1815333072.USD","LU0310800379.SGD","LU1778281490.HKD","LU1582987597.SGD","LU0080751232.USD","IE00BN8TJ469.HKD","LU0109391861.USD","LU1988902786.USD","LU0353189763.USD","LU0097036916.USD","LU2275660780.HKD","LU2028103732.USD","SGXZ23171101.USD","LU1670711040.USD","LU1301847155.USD","LU1181866309.USD","LU1037948897.HKD","LU0289960550.SGD","LU2430703178.SGD","LU0957808578.USD","LU0256863902.USD","LU2592432038.USD","LU1868836757.USD","IE0004445015.USD","LU2271345857.HKD","LU0466842654.USD","LU1267930573.SGD","LU0820561818.USD","LU1923622614.USD","LU1804176565.USD","MSFO","LU0320765992.SGD","LU1188199696.SGD","BK4511","LU1989764664.SGD","TSLS","LU1699723380.USD","LU0345769631.USD","IE00B3T34201.USD","LU1400636574.HKD","LU0056508442.USD","LU1935042488.USD","MSFD","TRIP","LU2168564222.USD","BK4592","LU0130102774.USD","LU2250418816.HKD","LU0323240290.USD","LU1791710582.SGD","LU2360107325.USD","TSLL","LU1316542783.SGD","LU2125154778.USD","LU2347655156.SGD","LU2458330169.SGD","LU2108987350.USD","LU1046421795.USD","BK4099","LU1623119135.USD","LU0314106906.USD","LU2403377893.USD","IE00BFSS7M15.SGD","LU1861558580.USD","GB00B4LPDJ14.GBP","LU1366333091.USD","LU0823434583.USD","LU0994945656.USD","LU0949170426.SGD","LU1037948541.HKD","MSFL","LU0094547139.USD","TSLA","LU2213496289.HKD","IE000W1ABFV2.USD","LU2210149790.SGD","LU0158827948.USD","LU0633140560.USD","LU1580142542.USD","SG9999015945.SGD","LU2168563687.JPY","SG9999014880.SGD","LU0683595622.HKD","LU2471134523.USD","LU1059921491.USD","IE000YTNTUN2.SGD","LU1629891620.HKD","LU0633140727.USD","BK0014","LU0211331839.USD","LU0348723411.USD","LU0689472784.USD","LU1496350502.SGD","LU1551013342.USD","IE0002270589.USD","TSLT","IE00BK4W5L77.USD","LU0095938881.EUR","IE00BK4W5M84.HKD","LU0208291251.USD","LU2242650005.HKD","LU2289578879.USD","LU2133065610.SGD","IE00BJJMRY28.SGD","LU0965508806.USD","IE0004091025.USD","BK4588","LU0171293334.USD","LU1323610961.USD","LU0158827781.USD","LU2433249047.HKD","LU2764262908.HKD","LU0308772762.SGD","LU0417517546.SGD","MSFW","LU0557290698.USD","LU0784385840.USD","LU2552382132.HKD","LU1721428933.USD","LU2746668974.SGD","LU0070302665.USD","LU1582986433.USD","LU0006306889.USD","LU2106854487.HKD","BK4567","LU2463028550.USD","BK4566","SGXZ81514606.USD","LU1084165304.USD","LU2404859741.USD","BK0188","LU2191332357.HKD","LU1997245177.USD","LU2097829019.USD","LU2896262040.SGD","LU0061475181.USD","IE00BDRTCR15.USD","LU2148510915.USD","LU0820562030.AUD","LU1670628061.USD","BK4516","LU0345770993.USD","LU2272731600.USD","LU0820561909.HKD","LU0889565916.HKD","LU2237443549.SGD","LU1582987324.SGD","LU0106261372.USD","BK4587","LU2095319765.USD","IE0034235295.USD","LU2077746001.SGD","LU0823411888.USD","LU2360107168.USD","LU2211815571.USD","SGXZ51526630.SGD","LU2756315664.SGD","LU2381873111.SGD","LU0868494617.USD","LU0070217475.USD","LU2746668461.USD","IE00B775H168.HKD","IE00BMPRXQ63.HKD","LU2092627202.USD","LU1236620750.USD","LU0081259029.USD","LU1236620834.HKD","IE000ITXATA3.USD","SG9999002224.SGD","IE00B1BXHZ80.USD","LU0238689110.USD","LU2505996681.GBP","LU0058720904.USD","IE00BMPRXR70.SGD","IE00B19Z3B42.SGD","BK4528","LU0456855351.SGD","LU2602419157.SGD","TSLO","LU0289941410.SGD","LU1718418525.SGD","LU1244550221.USD","BK4548","LU0289961442.SGD","HK0000914660.USD","IE00B19Z8W00.USD","IE00B4JS1V06.HKD","GB00BDT5M118.USD","LU1280957306.USD","LU2417539215.USD","LU2089984988.USD","BK0070","LU0788109477.HKD","LU2452424414.USD","IE00BJJMRX11.SGD","LU0096362180.USD","LU1868837300.USD","LU2750360997.AUD","LU1506573853.SGD","LU1674673428.USD","BK0169","LU0187121727.USD","LU0310799852.SGD","LU0724617625.USD","LU1267930490.SGD","LU1228905540.USD","LU2264538146.SGD","LU2506951958.HKD","LU2236285917.USD","LU2324357040.USD","LU2580892862.HKD","TSL","LU1633808545.USD","LU0029864427.USD","LU1548497426.USD","LU2023250330.USD","LU2125909593.SGD","LU0198837287.USD"],"gpt_icon":1},{"id":"1123197269","title":"吉利德科學保留大中華區以外全球獨家商業化權利，將向Galapagos支付銷售額20%-23%的特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1123197269","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123197269?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 06:17","pubTimestamp":1774304236,"startTime":"0","endTime":"0","summary":"根据最新协议条款，生物制药巨头吉利德科学将保留除大中华区以外的全球独家商业化权利。与此同时，该公司承诺将向合作伙伴Galapagos支付相当于净销售额20%至23%的特许权使用费。这一安排凸显了吉利德科学在全球市场战略布局中的精准定位，同时通过阶梯式分成模式强化了双方的利益共享机制。值得注意的是，大中华区的商业化权利将采用独立运作模式，这反映出该地区在市场规模、监管环境等方面具备的特殊性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","LU0114720955.EUR","IE0002270589.USD","LU2087621335.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU0861579265.USD","LU0965509283.SGD","LU1674673691.USD","LU1934455277.USD","LU0965509010.AUD","BK4566","LU1571399168.USD","LU2112291526.USD","LU0058720904.USD","IE00B7SZLL34.SGD","LU1061106388.HKD","LU1778281490.HKD","LU2324357040.USD","LU1839511570.USD","LU1066051498.USD","IE00BSNM7G36.USD","BK4568","IE00B3T34201.USD","BK4550","LU0320765992.SGD","LU0823416689.USD","GILD","LU1057294990.SGD","LU1585245621.USD","LU1037948541.HKD","LU1066053197.SGD","BK4588","LU1934455863.HKD","SG9999015952.SGD","IE00B19Z3581.USD","LU0965508806.USD","LU1430594728.SGD","SG9999015945.SGD","BK4578","LU0289739699.SGD","BK4532","LU1674673428.USD","BK4583","BK4139","LU1037948897.HKD","LU0122379950.USD","LU2468319806.SGD","LU1023059063.AUD","SG9999015978.USD","BK4585","SG9999015986.USD","LU0882574055.USD","LU0965509101.SGD","LU1934455194.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"1156422664","title":"吉利德科學將以16.75億美元現金對價收購Ouro Medicines全部流通股權","url":"https://stock-news.laohu8.com/highlight/detail?id=1156422664","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156422664?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 06:16","pubTimestamp":1774304173,"startTime":"0","endTime":"0","summary":"吉利德科学宣布，将以总额16.75亿美元的前期现金对价，收购生物技术公司Ouro Medicines的全部流通股权。此次交易将强化吉利德在创新疗法领域的布局，通过整合Ouro Medicines的专有技术平台，加速下一代治疗方案的开发进程。\n该收购案预计将于近期完成，届时Ouro Medicines的研发团队及技术资产将悉数并入吉利德科学的运营体系。市场观察人士指出，此举反映了大型药企通过战略性收购增强核心竞争力的趋势，尤其在基因编辑与细胞治疗等前沿领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0965509101.SGD","LU1037948897.HKD","LU1061106388.HKD","LU1571399168.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0234570918.USD","LU2324357040.USD","LU2468319806.SGD","IE00B3T34201.USD","LU1066051498.USD","SG9999015978.USD","LU0114720955.EUR","BK4583","LU0965509010.AUD","LU1057294990.SGD","BK4566","LU0058720904.USD","LU1778281490.HKD","LU0109394709.USD","LU0965509283.SGD","BK4139","LU0965508806.USD","IE0002270589.USD","LU1839511570.USD","BK4568","LU1934455194.USD","IE00BSNM7G36.USD","BK4578","IE00BKVL7J92.USD","LU1934455863.HKD","IE00B19Z3581.USD","SG9999015945.SGD","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU2087621335.USD","LU2112291526.USD","LU1674673691.USD","LU1934455277.USD","GILD","LU0122379950.USD","LU2089984988.USD","BK4550","SG9999015986.USD","LU0889565916.HKD","LU0289739699.SGD","LU1674673428.USD","LU0861579265.USD","BK4588","LU1037948541.HKD","BK4532","LU0320765992.SGD","LU0882574055.USD","LU1585245621.USD","LU1430594728.SGD","LU1066053197.SGD","IE00B7SZLL34.SGD","LU0823416689.USD"],"gpt_icon":0},{"id":"1172994317","title":"吉利德科學正與Galapagos就收購的Ouro Medicines資產展開研發合作深入談判","url":"https://stock-news.laohu8.com/highlight/detail?id=1172994317","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172994317?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 06:16","pubTimestamp":1774304171,"startTime":"0","endTime":"0","summary":"吉利德科学目前正与Galapagos公司进行深入磋商，双方拟就吉利德收购的Ouro Medicines资产展开潜在的研发合作。此次谈判标志着两家公司在创新药物开发领域的战略协同进入新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","BK4588","LU1023059063.AUD","LU1778281490.HKD","LU1674673428.USD","LU0861579265.USD","LU0320765992.SGD","LU1934455863.HKD","LU0234570918.USD","LU1066053197.SGD","LU0965508806.USD","SG9999015945.SGD","BK4568","LU2089984988.USD","BK4578","IE00BSNM7G36.USD","LU2112291526.USD","IE00B19Z3581.USD","BK4583","LU0889565916.HKD","LU1037948541.HKD","LU0109394709.USD","LU0965509101.SGD","BK4566","LU0122379950.USD","SG9999015986.USD","LU0965509010.AUD","SG9999015978.USD","LU2468319806.SGD","BK4550","LU0114720955.EUR","LU0882574055.USD","LU2087621335.USD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1934455194.USD","LU1934455277.USD","LU0965509283.SGD","LU1037948897.HKD","LU1839511570.USD","LU0823416689.USD","IE00BKVL7J92.USD","LU2324357040.USD","IE00B3T34201.USD","LU1430594728.SGD","GILD","IE00B7SZLL34.SGD","LU0289739699.SGD","BK4532","BK4585","LU1057294990.SGD","LU1674673691.USD","SG9999015952.SGD","LU1061106388.HKD","BK4139","LU1585245621.USD","LU0058720904.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"1145865834","title":"吉利德科學將收購Ouro Medicines，推進其首創的T細胞銜接器項目以治療自身免疫性疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1145865834","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145865834?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 06:16","pubTimestamp":1774304170,"startTime":"0","endTime":"0","summary":"吉利德科学已达成协议，将收购Ouro Medicines公司，此举旨在加速推进其首创的T细胞衔接器项目，该项目的重点在于开发针对自身免疫性疾病的创新疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0823416689.USD","BK4568","LU0114720955.EUR","LU1430594728.SGD","LU2112291526.USD","IE00BKVL7J92.USD","LU1778281490.HKD","LU1674673428.USD","LU1585245621.USD","LU1934455277.USD","LU1839511570.USD","SG9999015986.USD","LU1066051498.USD","IE00B3T34201.USD","LU1934455194.USD","GILD","BK4578","LU1037948541.HKD","IE00BSNM7G36.USD","LU0882574055.USD","LU2324357040.USD","LU1061106388.HKD","LU1934455863.HKD","BK4585","LU0109394709.USD","LU0289739699.SGD","BK4583","LU0889565916.HKD","IE00B7SZLL34.SGD","SG9999015945.SGD","LU0965509010.AUD","LU1037948897.HKD","LU0965508806.USD","IE00B19Z3B42.SGD","LU0861579265.USD","LU0965509283.SGD","LU0058720904.USD","LU0320765992.SGD","LU1571399168.USD","IE0002270589.USD","BK4550","LU0122379950.USD","LU0965509101.SGD","LU2087621335.USD","BK4588","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU2089984988.USD","SG9999015952.SGD","IE00B19Z3581.USD","LU0234570918.USD","LU1066053197.SGD","SG9999015978.USD","LU1057294990.SGD","LU1674673691.USD","LU2468319806.SGD","BK4532","BK4139"],"gpt_icon":0},{"id":"2621088819","title":"據英國《金融時報》報導，吉利德接近以最高20億美元收購生物技術公司Ouro Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2621088819","media":"路透中文","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621088819?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 00:42","pubTimestamp":1774284157,"startTime":"0","endTime":"0","summary":"据英国《金融时报》报导，吉利德接近以最高20亿美元收购生物技术公司Ouro Medicines路透3月23日 - 英国《金融时报》周一援引知情人士的话报导称，吉利德科学公司GILD.O即将以最高20亿美元的价格收购生物技术公司Ouro Medicines。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL4T40B1JO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","SG9999015945.SGD","LU0122379950.USD","LU2324357040.USD","LU0965509283.SGD","LU2087621335.USD","LU0965509010.AUD","LU1066051498.USD","BK4578","LU0823416689.USD","IE00B3T34201.USD","SG9999015952.SGD","BK4568","LU0114720955.EUR","IE00BZ1G4Q59.USD","GILD","LU1839511570.USD","LU1061106388.HKD","LU0058720904.USD","LU1057294990.SGD","LU1778281490.HKD","LU0965509101.SGD","LU0889565916.HKD","BK4532","IE00B19Z3581.USD","BK4588","LU2089984988.USD","IE00B19Z3B42.SGD","LU1934455194.USD","LU0320765992.SGD","IE0002270589.USD","LU1037948897.HKD","IE00BKVL7J92.USD","BK4585","LU1037948541.HKD","LU1674673691.USD","LU2112291526.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU2468319806.SGD","SG9999015978.USD","BK4566","LU1571399168.USD","LU1934455863.HKD","LU0861579265.USD","LU0289739699.SGD","LU0882574055.USD","LU0234570918.USD","LU1585245621.USD","LU1430594728.SGD"],"gpt_icon":0},{"id":"1175690757","title":"吉利德科學與Ouro Medicines談判進入後期階段 交易有望近日公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1175690757","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175690757?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 00:37","pubTimestamp":1774283835,"startTime":"0","endTime":"0","summary":"据知情人士透露，生物制药巨头吉利德科学与生物技术公司Ouro Medicines的并购谈判已进入关键阶段。双方正就最终条款进行磋商，若谈判顺利，这项备受业界关注的交易可能在未来数日内正式对外公告。此次潜在收购将强化吉利德在创新疗法领域的战略布局。市场观察人士指出，此举延续了吉利德近年来通过并购加速创新的战略路径。随着谈判进入收官阶段，两家公司股价近日均呈现波动上行态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1839511570.USD","LU1674673691.USD","LU0058720904.USD","SG9999015945.SGD","LU0320765992.SGD","LU0889565916.HKD","IE0002270589.USD","LU0965509010.AUD","LU1430594728.SGD","SG9999015986.USD","LU1057294990.SGD","SG9999015978.USD","BK4532","LU0965508806.USD","IE00BKVL7J92.USD","LU1674673428.USD","LU2087621335.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU2324357040.USD","GILD","BK4585","LU1585245621.USD","IE00B19Z3581.USD","LU1934455863.HKD","LU0861579265.USD","LU1934455194.USD","LU2089984988.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU1023059063.AUD","LU0823416689.USD","BK4583","LU1571399168.USD","LU0114720955.EUR","LU0122379950.USD","LU1037948541.HKD","IE00B7SZLL34.SGD","LU1778281490.HKD","LU2112291526.USD","LU1037948897.HKD","LU1066051498.USD","LU0965509283.SGD","LU0965509101.SGD","LU1934455277.USD","IE00B3T34201.USD","LU0234570918.USD","LU2468319806.SGD","BK4139","BK4568","BK4550","LU0882574055.USD","SG9999015952.SGD","LU0109394709.USD","BK4588","LU0289739699.SGD","BK4578"],"gpt_icon":0},{"id":"1102792638","title":"吉利德科學將以約15億美元現金預付款收購Ouro，若臨床試驗達標還將額外支付至少5億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102792638","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102792638?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 00:37","pubTimestamp":1774283833,"startTime":"0","endTime":"0","summary":"吉利德科学将向私人控股的Ouro公司投资者支付约15亿美元现金作为预付款。此外，若达成特定临床试验里程碑，吉利德科学还将额外支付至少5亿美元资金。该交易结构凸显了生物医药行业对创新疗法的高估值趋势，资金支付与研发进展深度绑定的模式也成为当前并购交易的新特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2089984988.USD","SG9999015978.USD","LU1037948541.HKD","IE00B19Z3B42.SGD","LU0965508806.USD","GILD","LU0114720955.EUR","LU0122379950.USD","LU1934455194.USD","LU0058720904.USD","IE00B19Z3581.USD","LU1061106388.HKD","BK4139","BK4550","BK4588","LU1037948897.HKD","LU2112291526.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","LU2468319806.SGD","BK4532","SG9999015986.USD","SG9999015952.SGD","LU1934455277.USD","LU0882574055.USD","LU1066051498.USD","SG9999015945.SGD","LU1066053197.SGD","BK4566","LU0234570918.USD","LU1057294990.SGD","LU0289739699.SGD","LU1023059063.AUD","LU1934455863.HKD","LU2324357040.USD","IE00BSNM7G36.USD","LU0889565916.HKD","BK4568","LU1585245621.USD","LU0109394709.USD","IE00B7SZLL34.SGD","BK4583","LU0823416689.USD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1674673691.USD","LU0965509283.SGD","LU1839511570.USD","IE0002270589.USD","LU0861579265.USD","LU1430594728.SGD","LU1778281490.HKD","BK4578","LU1571399168.USD","LU2087621335.USD","LU0965509101.SGD","LU1674673428.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2621770734","title":"BUZZ-Valneva股價暴跌，因萊姆病疫苗後期試驗未達標","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770734","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770734?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 19:31","pubTimestamp":1774265471,"startTime":"0","endTime":"0","summary":"3月23日 - ** ValnevaVLS.PA的股票在自动停止交易前暴跌了29%。此前，这家法国制药商及其美国同行辉瑞PFE.N在一项关键实验性疫苗的后期试验中未能达到预先确定的统计标准。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL4S40B0YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","SG9999002224.SGD","LU0306806265.USD","BK4592","IE00B19Z3581.USD","IE00BLSP4452.SGD","SG9999001176.USD","SG9999013999.USD","LU0225771236.USD","SG9999003800.SGD","IE00BLSP4239.USD","LU0170899867.USD","PFE","LU0456855351.SGD","BK4581","LU1066053197.SGD","LU0321505868.SGD","SGXZ57979304.SGD","LU0868494617.USD","BK4588","LU1057294990.SGD","IE000M9KFDE8.USD","LU0058720904.USD","BK4550","LU0289739699.SGD","BK4533","SG9999011175.SGD","LU0306807586.USD","LU0234572021.USD","BK4568","IE00B19Z3B42.SGD","BK4534","LU1894683264.USD","LU1023059063.AUD","LU0122379950.USD","LU1883839398.USD","LU1894683348.USD","LU1066051498.USD","SG9999002232.USD","IE00BBT3K403.USD","VALN","BK4007","BK4599","IE0002270589.USD","LU0225284248.USD","LU0321505439.SGD","BK4585","SG9999001176.SGD"],"gpt_icon":0},{"id":"1119255139","title":"輝瑞與Valneva聯合宣佈：萊姆病候選疫苗在3期VALOR試驗中展現強勁效力","url":"https://stock-news.laohu8.com/highlight/detail?id=1119255139","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119255139?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 18:48","pubTimestamp":1774262917,"startTime":"0","endTime":"0","summary":"辉瑞与Valneva SE今日共同公布，其合作研发的莱姆病候选疫苗在关键性3期VALOR临床试验中取得了显著的疗效数据。该试验结果证实，疫苗在预防莱姆病方面表现出强有力的保护作用，标志着这一备受关注的传染病预防项目取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VALN","LU0868494617.USD","IE0002270589.USD","BK4588","SG9999002224.SGD","LU0289739699.SGD","LU0306807586.USD","LU1023059063.AUD","SG9999011175.SGD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU1057294990.SGD","LU1894683264.USD","LU1894683348.USD","LU0170899867.USD","BK4534","SG9999003800.SGD","LU0306806265.USD","PFE","SGXZ57979304.SGD","SG9999001176.USD","LU0058720904.USD","LU0122379950.USD","IE000M9KFDE8.USD","BK4568","LU0225284248.USD","LU0225771236.USD","LU0234572021.USD","LU0456855351.SGD","LU0985481810.HKD","BK4585","BK4007","SG9999002232.USD","LU1066051498.USD","SG9999001176.SGD","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999013999.USD","BK4581","BK4599","IE00BLSP4452.SGD","BK4533","LU0321505439.SGD","LU0321505868.SGD","LU1883839398.USD","BK4550","BK4592","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"1138718711","title":"輝瑞萊姆病候選疫苗Lb6v在五歲及以上人群中預防效力超70%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138718711","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138718711?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 18:45","pubTimestamp":1774262748,"startTime":"0","endTime":"0","summary":"辉瑞公司宣布，其研发的莱姆病候选疫苗Lb6v在针对五岁及以上人群的临床试验中展现出卓越的预防效果，疫苗效力超过70%。这一数据为抗击由蜱虫传播的莱姆病提供了新的希望。\n研究结果表明，该疫苗在诱发人体免疫反应方面表现积极，能够有效降低莱姆病的感染风险。莱姆病若未及时治疗，可能引发神经系统及关节损伤等严重健康问题。\n此次进展标志着辉瑞在传染病疫苗领域取得重要突破，有望填补当前莱姆病预防领域的空白。下一步，辉瑞将继续推进疫苗的临床研发与监管申报工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU0868494617.USD","LU1883839398.USD","LU0456855351.SGD","IE00B19Z3B42.SGD","BK4592","IE00BBT3K403.USD","IE00B19Z3581.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0321505439.SGD","LU1066051498.USD","BK4588","LU1894683264.USD","LU0289739699.SGD","SGXZ57979304.SGD","SG9999002232.USD","SG9999001176.SGD","IE000M9KFDE8.USD","BK4007","SG9999011175.SGD","LU0122379950.USD","LU0321505868.SGD","BK4533","LU1023059063.AUD","BK4585","BK4599","LU0234572021.USD","SG9999003800.SGD","LU0306807586.USD","BK4534","BK4550","LU0306806265.USD","LU1057294990.SGD","PFE","LU1066053197.SGD","SG9999002224.SGD","SG9999013999.USD","LU0058720904.USD","SG9999001176.USD","BK4581","LU1894683348.USD","LU0225771236.USD","LU0170899867.USD","BK4568","LU0225284248.USD","IE0002270589.USD"],"gpt_icon":0},{"id":"1132141086","title":"輝瑞：Lb6v候選疫苗耐受性良好 分析時未發現安全性問題","url":"https://stock-news.laohu8.com/highlight/detail?id=1132141086","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132141086?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 18:45","pubTimestamp":1774262746,"startTime":"0","endTime":"0","summary":"辉瑞公司宣布，其研发的Lb6v候选疫苗在试验中表现出良好的耐受性，截至数据分析时，未发现任何安全性问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU1057294990.SGD","SG9999001176.SGD","SG9999013999.USD","LU0289739699.SGD","BK4581","BK4599","PFE","SGXZ57979304.SGD","BK4568","LU0234572021.USD","LU0225771236.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","LU0306807586.USD","SG9999003800.SGD","LU1883839398.USD","LU0170899867.USD","BK4592","LU0058720904.USD","LU0456855351.SGD","SG9999011175.SGD","BK4588","SG9999001176.USD","LU0321505439.SGD","LU1894683264.USD","BK4007","LU0985481810.HKD","IE00BBT3K403.USD","BK4585","LU1894683348.USD","IE0002270589.USD","LU0122379950.USD","LU0321505868.SGD","LU1023059063.AUD","IE000M9KFDE8.USD","SG9999002224.SGD","BK4533","LU1066053197.SGD","LU0225284248.USD","BK4550","LU0868494617.USD","LU0306806265.USD","SG9999002232.USD","BK4534","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2621777862","title":"輝瑞-Valneva 萊姆病疫苗在後期試驗中顯示出超過 70% 的療效","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777862","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621777862?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 18:45","pubTimestamp":1774262726,"startTime":"0","endTime":"0","summary":"辉瑞-Valneva 莱姆病疫苗在后期试验中显示出超过 70% 的疗效路透3月23日 - 美国制药商辉瑞公司PFE.N和法国Valneva公司VLS.PA周一称，它们的莱姆病试验性疫苗在一项后期试验中显示出70%以上的疗效。虽然辉瑞-Valneva公司的疫苗在第四次注射后28天内显示出73.2%的有效率，但由于试验中莱姆病例少于预期，数据点数量较少，因此在第一次分析中未能达到主要目标。去年，Valneva 公司表示，预计辉瑞公司将在疫苗获批后的 2027 年下半年推出该疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL4T40B0VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0321505868.SGD","SG9999003800.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4007","LU1983299246.USD","IE00B3T34201.USD","LU0321505439.SGD","LU0122379950.USD","LU1035777561.USD","LU1066053197.SGD","LU0306806265.USD","LU1046248800.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0203347892.USD","IE00BBT3K403.USD","LU0971552673.USD","LU0058720904.USD","LU1670756490.USD","LU1202635105.USD","IE00BLSP4239.USD","BK5011","LU0161305163.EUR","LU0306807586.USD","LU0203345920.USD","LU0575583348.USD","PFE","LU0211331839.USD","IE00BQJZX424.USD","IE0034235071.USD","LU0545562505.USD","LU1400636491.USD","IE0002270589.USD","LU0985481810.HKD","LU1309081286.SGD","IE00BWDBJ516.SGD","BK4581","LU0289739699.SGD","LU1098665638.USD","LU1228905037.USD","LU1645745479.HKD","BK4568","LU1400636574.HKD","LU1481599808.USD","LU1400636657.SGD","SG9999002232.USD","BK4550","LU1057294990.SGD","SG9999001176.SGD","LU0868494617.USD","BK4534","BK4588","BK4592","LU1894683348.USD","LU1487256676.USD","BK4599","LU0225771236.USD","LU1228905540.USD","LU0109981661.USD","SG9999013999.USD","SG9999011175.SGD","LU0170899867.USD","LU1015430645.USD","LU1302929846.USD","VALN","BK4533","SG9999001176.USD","LU1066051498.USD","LU1481600234.SGD","LU0456855351.SGD","LU1894683264.USD","LU0971552830.HKD","LU0225284248.USD","BK4585","LU1064927863.SGD","LU1883839398.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":81,"code":"91000000","status":"200"}]}}